Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.22.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid- In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Deficit
Beginning balance at Sep. 30, 2020 $ 81,519 $ 141   $ 124,435 $ (646) $ (42,411)
Beginning balance (in shares) at Sep. 30, 2020   14,063,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 719         719
Translation adjustment 595       595  
Stock compensation expense 65     65    
Stock options exercised 135     135    
Stock options exercised (in shares)   28,000        
Ending balance at Dec. 31, 2020 83,033 $ 141   124,635 (51) (41,692)
Ending balance (in shares) at Dec. 31, 2020   14,091,000        
Beginning balance at Sep. 30, 2020 81,519 $ 141   124,435 (646) (42,411)
Beginning balance (in shares) at Sep. 30, 2020   14,063,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 473          
Ending balance at Mar. 31, 2021 83,441 $ 142   125,513 (276) (41,938)
Ending balance (in shares) at Mar. 31, 2021   14,222,000        
Beginning balance at Dec. 31, 2020 83,033 $ 141   124,635 (51) (41,692)
Beginning balance (in shares) at Dec. 31, 2020   14,091,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (246)         (246)
Translation adjustment (225)       (225)  
Stock compensation expense 84     84    
Stock options exercised 795 $ 1   794    
Stock options exercised (in shares)   131,000        
Ending balance at Mar. 31, 2021 83,441 $ 142   125,513 (276) (41,938)
Ending balance (in shares) at Mar. 31, 2021   14,222,000        
Beginning balance at Sep. 30, 2021 $ 85,634 $ 143   126,380 14 (40,903)
Beginning balance (in shares) at Sep. 30, 2021 14,304,492 14,304,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 997         997
Translation adjustment 237       237  
Stock compensation expense 103     103    
Repurchase of treasury stock (2,713)   $ (2,713)      
Repurchase of treasury stock (in shares)     (291,000)      
Retirement of treasury stock   $ (3) $ 2,713 (2,122)   (588)
Retirement of treasury stock (in shares)   (291,000) 291,000      
Stock options exercised 69     69    
Stock options exercised (in shares)   12,000        
Ending balance at Dec. 31, 2021 84,327 $ 140   124,430 251 (40,494)
Ending balance (in shares) at Dec. 31, 2021   14,025,000        
Beginning balance at Sep. 30, 2021 $ 85,634 $ 143   126,380 14 (40,903)
Beginning balance (in shares) at Sep. 30, 2021 14,304,492 14,304,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 2,962          
Ending balance at Mar. 31, 2022 $ 85,158 $ 139   123,534 353 (38,868)
Ending balance (in shares) at Mar. 31, 2022 13,887,050 13,887,000        
Beginning balance at Dec. 31, 2021 $ 84,327 $ 140   124,430 251 (40,494)
Beginning balance (in shares) at Dec. 31, 2021   14,025,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,965         1,965
Translation adjustment 102       102  
Stock compensation expense 137     137    
Repurchase of treasury stock (1,402)   $ (1,402)      
Repurchase of treasury stock (in shares)     (143,000)      
Retirement of treasury stock   $ (1) $ 1,402 (1,062)   (339)
Retirement of treasury stock (in shares)   (143,000) 143,000      
Stock options exercised 29     29    
Stock options exercised (in shares)   5,000        
Ending balance at Mar. 31, 2022 $ 85,158 $ 139   $ 123,534 $ 353 $ (38,868)
Ending balance (in shares) at Mar. 31, 2022 13,887,050 13,887,000